AT
GILD icon

Avalon Trust’s Gilead Sciences GILD Stock Holding History

Avalon Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Hold
1,140
– – 0.01% 176
2026
Q1 		$159K Sell
1,140
-18
-2% -$2.52K 0.01% 168
2025
Q4 		$142K Sell
1,158
-100
-8% -$12.2K 0.01% 172
2025
Q3 		$140K Buy
1,258
+118
+10% +$13.4K 0.01% 193
2025
Q2 		$126K Buy
+1,140
New +$121K 0.01% 175

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Avalon Trust's GILD Position: Q2 2026 in Review

Avalon Trust held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,140 shares worth $144K. The position accounts for 0.01% of the portfolio, ranked #176.

Avalon Trust first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $159K in Q1 2026. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Avalon Trust held 1,140 shares of Gilead Sciences worth $144K as of Q2 2026.
  • Avalon Trust left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.01% of Avalon Trust's portfolio in Q2 2026, its #176 holding.
  • Avalon Trust first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • Avalon Trust's Gilead Sciences position peaked at $159K in Q1 2026.
  • 2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Avalon Trust's 13F filing for Q2 2026, filed 6 Aug 2026.